Regeneron (REGN) Tops Q2 EPS by $1.17
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $663.23 -1.92%
EPS Growth %: -15.8%
Financial Fact:
Cost of goods sold: 29.9M
Today's EPS Names:
CRMT, PKE, HELE, More
EPS Growth %: -15.8%
Financial Fact:
Cost of goods sold: 29.9M
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q2 EPS of $9.77, $1.17 better than the analyst estimate of $8.60. Revenue for the quarter came in at $2.86 billion versus the consensus estimate of $2.79 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Regeneron Pharma (REGN) PT Lowered to $730 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
